The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma–CLEAP 004 study
CX Yang, YX Pan, F Ye, XD Zhu, J Xue, X Li… - Frontiers in …, 2024 - frontiersin.org
Background For decades, stratification criteria for first-line clinical studies have been highly
uniform. However, there is no principle or consensus for restratification after systemic …
uniform. However, there is no principle or consensus for restratification after systemic …